EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Tonix Pharmaceuticals Holding Corp. (TNXP) had EBITDA Margin of -943.87% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$13.11M |
|
$-124.02M |
|
$6.64M |
|
$6.47M |
|
$138.81M |
|
$-125.70M |
|
$1.68M |
|
$-124.02M |
|
$-124.02M |
|
$-124.02M |
|
$-124.02M |
|
$-124.02M |
|
$-124.02M |
|
$-125.70M |
|
$-123.71M |
|
8.51M |
|
8.51M |
|
$-14.57 |
|
$-14.57 |
|
| Balance Sheet Financials | |
$228.88M |
|
$44.46M |
|
$48.30M |
|
$277.17M |
|
$30.84M |
|
-- |
|
$1.18M |
|
$32.02M |
|
$245.15M |
|
$245.03M |
|
$245.15M |
|
12.79M |
|
| Cash Flow Statement Financials | |
$-99.84M |
|
$-4.53M |
|
$214.53M |
|
$99.68M |
|
$209.81M |
|
$110.13M |
|
$6.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
49.34% |
|
-959.05% |
|
-959.05% |
|
|
EBITDA Margin |
-943.87% |
-946.22% |
|
-946.22% |
|
$-103.21M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
1.10 |
|
2.09 |
|
174.63 |
|
-50.59% |
|
-50.61% |
|
-44.75% |
|
-50.59% |
|
$19.17 |
|
$-12.13 |
|
$-11.73 |
|